![]() |
|
The Relationship of Joint Hypermobility, Bone Mineral Density, and Osteoarthritis in the General Population: The Chingford Study
A. LOUISE DOLAN, DEBBIE J. HART, DAVID V. DOYLE, RODNEY GRAHAME, and TIM D. SPECTOR
ABSTRACT.
Methods. Joint hypermobility was assessed by the Beighton and the (more quantitative) Contompasis scores in 716 female subjects under followup in the Chingford Study (age range 53-72, mean 61 yrs, SD 5.8). Results. We found 79 of 716 subjects (11%) had a hypermobility score > 1/9 on the Beighton scale (spine in 75/79); 82/716 had a Contompasis score > 22 (normal < 18). Only one had a 4/9 Beighton score indicative of generalized joint hypermobility. Subjects with Contompasis > 22 were more physically active and less likely to smoke. They had a reduced risk of knee OA (joint space narrowing) (OR 0.48, 95% CI 0.27-0.83, after adjusting for age, height, weight, and activity), but no change in risk of OA in spine or hands. Hip BMD was increased by 3% in this more hypermobile subgroup (p < 0.05). A similar effect was seen for knee OA, but not BMD in those with a Beighton score > 1. Conclusion. Our data suggest that in this postmenopausal population the tendency to joint hypermobility may be a marker for fitness, manifested by reduced knee OA and increased hip BMD. The incidence of generalized hypermobility (Beighton > 4/9) was very low (0.14%) compared with the localized form (seen in 11%) and other studies. Those with mild degrees of hypermobility showed no evidence of premature OA or reduced BMD, as reported in some of the rarer heritable disorders of connective tissue. (J Rheumatol 2003;30:799-803) Key Indexing Terms:
HYPERMOBILITY
From the Department of Rheumatology, Queen Elizabeth Hospital; Twin Research and Genetic Epidemiology Unit, St. Thomas' Hospital; Whipps Cross Hospital; and University College London Hospitals, London, UK. A.L. Dolan, MA, FRCP, Department of Rheumatology, Queen Elizabeth Hospital; D.J. Hart, PhD; T.D. Spector, MD, FRCP, Twin Research and Genetic Epidemiology Unit, St. Thomas' Hospital; D.V. Doyle, FRCP, Whipps Cross Hospital; R. Grahame, MD, FRCP, University College London Hospitals. Address reprint requests to Dr. A.L. Dolan, Department of Rheumatology, Queen Elizabeth Hospital, Stadium Road, London, SE18 4QH, UK. E-mail: Ldolan@btinternet.com Submitted March 20, 2002; revision accepted September 19, 2002. |